Vitality Biopharma Developing Cannabis-derived Prodrugs for Inflammatory Bowel Disease
News
Vitality Biopharma of California has developed a new class of cannabis-derived cannabinoid prodrugs, known as cannabosides, which can enable the selective delivery of cannabidiol (CBD), a cannabinoid compound, to the intestinal tract, ... Read more